Operator: Greetings, and welcome to the DURECT Corporation Second Quarter Earnings Call. [Operator Instructions]. It is now my pleasure to introduce your host, Tim Papp, Chief Financial Officer.
By Colin Kellaher Durect Corp. shares tumbled more than 25% in premarket trading Thursday after the biopharmaceutical company said it was raising $15 million.